BioRestorative Accounts Payable vs Net Working Capital Analysis

BRTX Stock  USD 1.46  0.01  0.68%   
BioRestorative Therapies financial indicator trend analysis is way more than just evaluating BioRestorative Therapies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioRestorative Therapies is a good investment. Please check the relationship between BioRestorative Therapies Accounts Payable and its Net Working Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Accounts Payable vs Net Working Capital

Accounts Payable vs Net Working Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioRestorative Therapies Accounts Payable account and Net Working Capital. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between BioRestorative Therapies' Accounts Payable and Net Working Capital is -0.65. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of BioRestorative Therapies, assuming nothing else is changed. The correlation between historical values of BioRestorative Therapies' Accounts Payable and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of BioRestorative Therapies are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Accounts Payable i.e., BioRestorative Therapies' Accounts Payable and Net Working Capital go up and down completely randomly.

Correlation Coefficient

-0.65
Relationship DirectionNegative 
Relationship StrengthWeak

Accounts Payable

An accounting item on the balance sheet that represents BioRestorative Therapies obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of BioRestorative Therapies are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Net Working Capital

Most indicators from BioRestorative Therapies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioRestorative Therapies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.Selling General Administrative is likely to drop to about 7.4 M in 2024. Issuance Of Capital Stock is likely to drop to about 2.2 M in 2024

BioRestorative Therapies fundamental ratios Correlations

0.15-0.650.96-0.640.95-0.730.05-0.290.24-0.70.26-0.84-0.80.7-0.05-0.390.970.72-0.310.840.970.38-0.6-0.47-0.63
0.150.220.040.090.250.16-0.25-0.370.610.050.460.23-0.44-0.250.460.050.190.41-0.30.340.190.110.170.12-0.45
-0.650.22-0.80.77-0.570.94-0.28-0.330.290.740.040.590.32-0.380.340.13-0.57-0.46-0.26-0.38-0.57-0.220.910.530.25
0.960.04-0.8-0.720.89-0.880.16-0.130.12-0.810.19-0.82-0.680.63-0.18-0.40.910.7-0.220.740.910.38-0.74-0.58-0.51
-0.640.090.77-0.72-0.60.73-0.23-0.350.350.410.110.440.39-0.350.5-0.1-0.58-0.53-0.27-0.45-0.58-0.340.530.60.48
0.950.25-0.570.89-0.6-0.64-0.23-0.330.28-0.640.22-0.77-0.90.640.02-0.30.990.82-0.230.930.990.49-0.56-0.42-0.71
-0.730.160.94-0.880.73-0.64-0.33-0.170.120.88-0.020.640.36-0.380.380.36-0.64-0.550.01-0.43-0.64-0.30.850.670.19
0.05-0.25-0.280.16-0.23-0.23-0.330.24-0.24-0.240.10.020.34-0.14-0.35-0.23-0.19-0.16-0.22-0.3-0.2-0.1-0.2-0.210.24
-0.29-0.37-0.33-0.13-0.35-0.33-0.170.24-0.640.12-0.520.180.52-0.17-0.590.6-0.33-0.320.76-0.49-0.33-0.22-0.18-0.230.28
0.240.610.290.120.350.280.12-0.24-0.64-0.190.78-0.11-0.420.050.62-0.320.270.32-0.620.380.270.280.110.14-0.29
-0.70.050.74-0.810.41-0.640.88-0.240.12-0.19-0.20.610.46-0.280.150.58-0.63-0.640.29-0.52-0.63-0.450.830.50.13
0.260.460.040.190.110.22-0.020.1-0.520.78-0.2-0.12-0.40.060.51-0.140.210.25-0.380.370.210.18-0.10.36-0.48
-0.840.230.59-0.820.44-0.770.640.020.18-0.110.61-0.120.53-0.930.140.33-0.84-0.320.15-0.6-0.83-0.110.560.340.39
-0.8-0.440.32-0.680.39-0.90.360.340.52-0.420.46-0.40.53-0.43-0.240.2-0.86-0.840.25-0.99-0.86-0.560.410.070.83
0.7-0.25-0.380.63-0.350.64-0.38-0.14-0.170.05-0.280.06-0.93-0.43-0.1-0.140.730.11-0.040.480.73-0.08-0.3-0.18-0.41
-0.050.460.34-0.180.50.020.38-0.35-0.590.620.150.510.14-0.24-0.1-0.240.020.11-0.360.190.020.070.120.33-0.12
-0.390.050.13-0.4-0.1-0.30.36-0.230.6-0.320.58-0.140.330.2-0.14-0.24-0.32-0.320.81-0.23-0.32-0.230.210.4-0.26
0.970.19-0.570.91-0.580.99-0.64-0.19-0.330.27-0.630.21-0.84-0.860.730.02-0.320.74-0.240.891.00.4-0.55-0.43-0.67
0.720.41-0.460.7-0.530.82-0.55-0.16-0.320.32-0.640.25-0.32-0.840.110.11-0.320.74-0.290.860.740.78-0.52-0.43-0.59
-0.31-0.3-0.26-0.22-0.27-0.230.01-0.220.76-0.620.29-0.380.150.25-0.04-0.360.81-0.24-0.29-0.25-0.24-0.23-0.170.19-0.05
0.840.34-0.380.74-0.450.93-0.43-0.3-0.490.38-0.520.37-0.6-0.990.480.19-0.230.890.86-0.250.890.59-0.47-0.14-0.81
0.970.19-0.570.91-0.580.99-0.64-0.2-0.330.27-0.630.21-0.83-0.860.730.02-0.321.00.74-0.240.890.4-0.55-0.42-0.67
0.380.11-0.220.38-0.340.49-0.3-0.1-0.220.28-0.450.18-0.11-0.56-0.080.07-0.230.40.78-0.230.590.4-0.35-0.31-0.36
-0.60.170.91-0.740.53-0.560.85-0.2-0.180.110.83-0.10.560.41-0.30.120.21-0.55-0.52-0.17-0.47-0.55-0.350.320.24
-0.470.120.53-0.580.6-0.420.67-0.21-0.230.140.50.360.340.07-0.180.330.4-0.43-0.430.19-0.14-0.42-0.310.32-0.14
-0.63-0.450.25-0.510.48-0.710.190.240.28-0.290.13-0.480.390.83-0.41-0.12-0.26-0.67-0.59-0.05-0.81-0.67-0.360.24-0.14
Click cells to compare fundamentals

BioRestorative Therapies Account Relationship Matchups

BioRestorative Therapies fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.5M4.3M22.5M16.4M12.6M13.2M
Other Current Liab4.5M609.2K15.9K5.5M2.3M1.7M
Total Current Liabilities13.7M1.0M363.8K440.3K2.6M2.5M
Total Stockholder Equity(12.8M)(1.3M)21.6M15.8M10.0M10.5M
Accounts Payable2.0M118.9K50.8K170.9K189.4K179.9K
Other Current Assets35.2K105.4K436.2K363.1K305.2K320.5K
Total Liab14.2M5.7M856.5K602.6K2.6M2.5M
Intangible Assets739.2K664.3K589.7K803.4K713.7K971.2K
Common Stock7.8K286.2K353.0369.0471.0447.45
Property Plant Equipment658.3K21.9K395.8K502.8K578.2K351.7K
Short Long Term Debt Total7.8M4.8M670.7K301.6K162.3K154.2K
Property Plant And Equipment Net658.3K495.8K395.8K502.8K507.5K420.0K
Net Debt7.8M1.7M(20.4M)(1.4M)(722.1K)(686.0K)
Retained Earnings(78.6M)(89.8M)(134.1M)(152.6M)(146.7M)(139.4M)
Cash1.7K3.1M21.0M1.7M884.4K840.2K
Non Current Assets Total1.4M1.2M985.5K1.3M1.2M1.3M
Long Term Debt194.3K523.9K4.3M191.0K219.7K208.7K
Cash And Short Term Investments1.7K3.1M21.0M14.7M11.1M11.6M
Common Stock Shares Outstanding19.5K394.7K1.2M3.6M4.2M4.4M
Liabilities And Stockholders Equity1.5M4.3M22.5M16.4M12.6M13.2M
Non Current Liabilities Total521.9K4.6M492.7K162.3K186.7K177.3K
Other Stockholder Equity65.8M88.2M155.7M146.6M156.7M164.5M
Total Current Assets68.9K3.2M21.5M15.1M11.4M12.0M
Short Term Debt7.2M316.7K297.1K278.7K162.3K154.2K
Net Tangible Assets(13.5M)(2.0M)21.0M15.0M17.3M18.1M
Short Long Term Debt3.5M3.6M7.1M59.0K53.1K50.4K
Net Receivables32K17K5K16K19.3K22.7K
Net Invested Capital(5.6M)2.9M21.8M15.8M10.0M5.9M
Net Working Capital(13.7M)2.1M21.1M14.7M8.8M9.2M
Capital Stock7.8K286.2K15.8K15.6K17.9K17.0K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.